Revenue

A California company has turned raw dairy biogas into jet fuel, a world-first that promises to tackle aviation's climate crisis and create a new gold rush for farmers.

For 20 years, Montreal's Segal Cancer Centre has quietly built a world-class innovation engine. We dissect its unique model where research, care, and funding converge.

After eight years in stealth, an American 3D printing company is challenging the hype-driven tech world with a simple idea: build a reliable product first.

With audited reserves and public funds, exchanges are pushing for transparency. We dive deep into whether this new model for accountability can truly secure your assets.

LONGi celebrates a massive solar milestone, but with industry margins squeezed, we analyze if its high-efficiency bet can deliver long-term value.

The Shanghai Museum dedicates its entire venue to 3,000 artifacts from Mexico and Peru. This isn't just an exhibition; it's a new model for cultural infrastructure.

A new partnership between Argonaut and Ensera aims to untangle complex supply chains for drug-device products, potentially leveling the field for smaller innovators.

Johnson & Johnson's massive investment in Jacksonville promises economic growth, but the real story is a strategic pivot to secure the U.S. healthcare supply chain.

A small Canadian firm's breakthrough in water technology could slash energy use in major industries. But can it overcome the hurdles to commercialization?

A new platform claims to be the first to unify trust, risk, and security management for both AI and quantum threats. Is this the dawn of a new era for GRC?

Amid rising cyber threats, Toobit launches a security hub with verifiable Proof of Reserves. But does this bet on transparency truly redefine trust?

China's Atom Therapeutics is advancing a dual-threat pipeline, with novel drugs for gout and a groundbreaking anti-inflammatory aimed at cardiovascular disease.

Amid a frenzied market for drill rigs, Eminent Gold begins a pivotal program in Nevada. It's a story of high-tech exploration and strategic patience.

Skanska's massive Karlstad hospital project promises a high-tech future, but can a building solve deep-seated healthcare system challenges like staff shortages?

A new pact between BioSTL and the UK's NHS is set to make St. Louis a prime U.S. launchpad for health tech, turning global innovation into local impact.

Ottawa's new data privacy act isn't just an update to old rules. It's a strategic move to redefine trust, control, and Canada's role in the global digital economy.

As JetZero breaks ground on a factory set to create 14,500 jobs, its partnership with Deloitte aims to solve a critical problem: who will fill them?

Colorado's lottery modernization is a major commercialization win for Pollard Banknote, signaling a new era of digital engagement and revenue for state programs.

While biopharma braces for Medicare price negotiations, Halozyme claims immunity. Is its tech-licensing model the new blueprint for resilience or just a loophole?

After months of conflict sent oil prices soaring, a landmark US-Iran deal promises relief. But is this a lasting peace or just a pause for breath?